National Research Corporation $NRC Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC reduced its stake in National Research Corporation (NASDAQ:NRC) by 9.5% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 404,298 shares of the company’s stock after selling 42,275 shares during the period. Geode Capital Management LLC’s holdings in National Research were worth $6,793,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of NRC. Nuveen LLC acquired a new stake in National Research during the 1st quarter valued at approximately $502,000. American Century Companies Inc. increased its stake in shares of National Research by 7.3% in the first quarter. American Century Companies Inc. now owns 42,102 shares of the company’s stock worth $539,000 after acquiring an additional 2,848 shares during the period. Aviso Financial Inc. raised its holdings in shares of National Research by 37.2% during the first quarter. Aviso Financial Inc. now owns 3,076 shares of the company’s stock worth $39,000 after purchasing an additional 834 shares during the last quarter. AlphaQuest LLC lifted its position in National Research by 76.2% during the first quarter. AlphaQuest LLC now owns 33,807 shares of the company’s stock valued at $433,000 after purchasing an additional 14,619 shares during the period. Finally, Cubist Systematic Strategies LLC purchased a new stake in National Research in the first quarter valued at $118,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of National Research in a report on Monday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

National Research Trading Down 2.8%

Shares of National Research stock opened at $15.87 on Friday. The firm has a 50-day simple moving average of $14.00 and a two-hundred day simple moving average of $14.75. The company has a debt-to-equity ratio of 5.31, a quick ratio of 0.53 and a current ratio of 0.53. National Research Corporation has a fifty-two week low of $9.76 and a fifty-two week high of $19.71. The company has a market cap of $359.61 million, a P/E ratio of 22.67 and a beta of 0.45.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Monday, October 27th. The company reported $0.23 EPS for the quarter. The business had revenue of $34.61 million during the quarter. National Research had a return on equity of 98.26% and a net margin of 11.76%.

National Research Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 9th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, December 26th. This is a positive change from National Research’s previous quarterly dividend of $0.12. This represents a $0.64 annualized dividend and a yield of 4.0%. National Research’s payout ratio is 68.57%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.